Virtu KCG Holdings’s CASI Pharmaceuticals CASI Stock Holding History

Virtu KCG Holdings’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-2,729	Closed	-$39K	–	2920
2017 Q1	$39K	Buy	+2,729	New	+$37.1K	﹤0.01%	2883
2016 Q1	–	Sell	-1,449	Closed	-$14K	–	2853
2015 Q4	$14K	Sell	1,449 -543	-27%	-$6.16K	﹤0.01%	3342
2015 Q3	$21K	Buy	+1,992	New	+$28.7K	﹤0.01%	3145
2014 Q2	–	Sell	-1,018	Closed	-$19K	–	3666
2014 Q1	$19K	Sell	1,018 -474	-32%	-$8.97K	﹤0.01%	3432
2013 Q4	$25K	Buy	+1,492	New	+$25.2K	﹤0.01%	3699

Other funds holding CASI

WSCM

Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return

WSC

Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return

Virtu KCG Holdings's CASI Position: Q2 2017 in Review

Virtu KCG Holdings sold out of CASI Pharmaceuticals (CASI) in Q2 2017, closing a stake of 2,729 shares — an estimated $39K sold.

Virtu KCG Holdings first reported a position in CASI in Q4 2013 and held it in 5 quarters. The position peaked at $39K in Q1 2017. 27 funds tracked by Wall St. Rank hold CASI as of Q2 2017.

Virtu KCG Holdings reported no remaining CASI Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
Virtu KCG Holdings sold 2,729 CASI Pharmaceuticals shares in Q2 2017, an estimated $39K.
Virtu KCG Holdings first reported a position in CASI Pharmaceuticals in Q4 2013 and held it in 5 quarters.
Virtu KCG Holdings's CASI Pharmaceuticals position peaked at $39K in Q1 2017.
27 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.